Shadow Banking News
Experts: Lack of remorse could bite 'Pharma Bro'
A securities fraud conviction has done nothing to quiet Martin Shkreli and experts say that could hurt the so-called "Pharma Bro" at sentencing
Convicted 'Pharma Bro' has an image problem, lawyer concedes
Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide 'Pharma Bro' persona on social media, has been convicted at his federal securities fraud trial
Jobless rate raises question: How much better can it get? WASHINGTON (AP) — A drop in the unemployment rate to a 16-year low raises a tantalizing question about the job market: How much better can it get? Earlier this year, economists worried that businesses would struggle to find the workers they
The Latest: Shkreli lawyer acknowledges an 'image issue'
A lawyer for "Pharma Bro" Martin Shkreli is acknowledging that his client has "an image issue" following his conviction at his securities fraud trial
'Pharma Bro' Martin Shkreli 'delighted' by verdict in securities fraud trial
A jury has found "Phama Bro" Martin Shkreli , the former pharmaceutical CEO notorious for drastically increasing the price of a life-saving drug, guilty on three of eight counts in an unrelated federal securities fraud trial. Shkreli, 34, was accused of funneling money from MSMB Capital and MSMB
2 Martin Shkrelis turn up in same courtroom, with same judge
A defendant in a money laundering case has at least two things in common with "Pharma Bro" Martin Shkreli _ the same name and the same judge
Martin Shkreli's fate in hands of the jury
The former drug executive, 34, is still speaking his mind on social media as he awaits a verdict in his federal securities fraud trial that could land him up to 20 years in prison.
Chris Connelly interviews Andie MacDowell for 'The Callback'
I'm Chris Connelly and you were watching the call back as the series of longer form interviews were doing with people with whom I've had some sort of professional history over the three and a half decades that I've been talking to people in the entertainment industry. Today's it is with Andy
Shkreli's trial sees nearly 250 potential jurors dismissed
The so called bad boys of pharmaceuticals Martin's Riley. Who became infamous for jacking up the price of the lifesaving drug dare print is now in court on securities fraud charges are really cared about people. But three days in nearly 200 potential jurors later. His lawyers say they're struggling
Trial of former drug company executive Martin Shkreli faces difficulty finding impartial jurors
Shkreli faces federal charges for securities fraud; he's also known for raising the price of a lifesaving drug by more than 5,000 percent.